:: Library Catalog

Image de couverture de livre

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Iulia Minciuna, Horia Stefanescu
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	https://onlinelibrary.wiley.com/doi/10.1111/apt.18113
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Editorial: Reading the cholate—A new gateway to portal hypertension and oesophageal varices: Authors' reply
par: Tarek Hassanein, et autres
Publié: (2024)

Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices
par: Tarek Hassanein, et autres
Publié: (2024)

Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study
par: Maria Mironova, et autres
Publié: (2024)

Editorial: Eosinophilic oesophagitis coming of age—Increasing frequency and wider age range—Authors' reply
par: Akshatha Kiran, et autres
Publié: (2024)

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms–still a long way to go…
par: Sabine Roman, et autres
Publié: (2024)

Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding—the promise, controversies and future directions. Author's reply
par: Sagnik Biswas, et autres
Publié: (2024)

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply'
par: Francesco Calabrese, et autres
Publié: (2024)

Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find
par: Leya Nedumannil, et autres
Publié: (2024)

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease
par: Jannis Kountouras, et autres
Publié: (2024)

Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply
par: Sagnik Biswas, et autres
Publié: (2024)

Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study
par: Francesco Calabrese, et autres
Publié: (2024)

Letter: Potential impact ofHelicobacter pyloriinfection on oesophageal disorders in chronic liver disease—Authors' reply
par: Francisco Idalsoaga, et autres
Publié: (2024)

Editorial: Sonographic assessment of colonic content—A new tool for constipation?
par: Giovanni Maconi, et autres
Publié: (2024)

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study
par: Nathan Grellier, et autres
Publié: (2024)

Editorial: Sonographic assessment of colonic content—A new tool for constipation? Authors' reply
par: R. M. Mathias, et autres
Publié: (2024)

Editorial: Gastrointestinal symptoms—A world of differences
par: Kevin W. Olden
Publié: (2024)

Editorial: To Stop Or Not To Stop: Is It Still A Question?
par: Stephan R. Vavricka, et autres
Publié: (2024)

Editorial: Quantity is important!
par: Chee‐Kiat Tan
Publié: (2024)

Editorial: Targeting Urgency in IBD —A Historical Divide
par: Daniele Noviello, et autres
Publié: (2025)

Editorial: Plants against animals
par: Einar S. Björnsson
Publié: (2024)

Editorial: Terlipressin Induced Bradycardia
par: Nancy Reau, et autres
Publié: (2025)

Editorial: Upadacitinib—A Promising Induction Agent for Paediatric Crohn's Disease?
par: Vincenzo Stranges, et autres
Publié: (2025)

Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues
par: Stephanie Gold, et autres
Publié: (2025)

Editorial: Combination Therapies for MASH : A Step Forward or More Complexity?
par: Xiao‐Dong Zhou, et autres
Publié: (2025)

Editorial: Targeting Urgency in IBD —A Historical Divide. Authors' Reply
par: Parul Tandon, et autres
Publié: (2025)

Editorial: Coeliac Disease and Women's Reproductive Health: A Lifelong Challenge
par: C. Ciacci, et autres
Publié: (2025)

Editorial: Quantity is important! Authors' reply
par: Marika Rudler, et autres
Publié: (2024)

Editorial: Another brick in the CDST wall
par: Aurelien Amiot, et autres
Publié: (2024)

Editorial: Upadacitinib in Perianal Crohn's Disease
par: Manjeet Kumar Goyal, et autres
Publié: (2026)

Editorial: Getting to the Heart of the Matter in IBD
par: Ashwin N. Ananthakrishnan
Publié: (2025)

Editorial: Breath Profiling in MASLD—A Step Towards Better Risk Stratification
par: Takefumi Kimura
Publié: (2025)

Editorial: Steroid‐Induced Diabetes in Autoimmune Hepatitis—A Call for Treatment Optimization
par: Pranab M. Barman
Publié: (2026)

Editorial: The Appendix—A Dead End for Treating Ulcerative Colitis, After All?
par: Johan D. Söderholm
Publié: (2025)

Editorial: Allostatic Load and Inflammatory Bowel Disease
par: Jeli Mendoza, et autres
Publié: (2024)

Editorial: Muscles at the expense of liver injury. Is it worth it?
par: C. Stephens
Publié: (2024)

Editorial: Defining corticosteroid use in clinical trials
par: J. Siffledeen
Publié: (2024)

Editorial: Cardiometabolic criteria matters inMASLD
par: Margaret L. P. Teng, et autres
Publié: (2024)

Editorial: Striving for Equitable Care in Ulcerative Colitis
par: Edward L. Barnes
Publié: (2025)

Editorial: Hyperferritinaemia—An Ironclad Biomarker for the Prognostication of MASLD?
par: Mark C. C. Cheah, et autres
Publié: (2025)

Editorial: Infliximab induction therapy in pediatric Crohn's disease—A cost‐effective strategy?
par: Neil Chanchlani, et autres
Publié: (2024)